- Home
- IART vs BCRX Comparison
IART vs BCRX Comparison
Compare IART & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IART | BCRX |
|---|---|---|
| Founded | 1989 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | IART | BCRX |
|---|---|---|
| Price | $13.03 | $7.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | $15.00 | ★ $19.00 |
| AVG Volume (30 Days) | 1.1M | ★ 4.6M |
| Earning Date | 10-30-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,642,966,000.00 | $599,816,000.00 |
| Revenue This Year | $3.51 | $41.57 |
| Revenue Next Year | $2.88 | $6.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.99 | ★ 45.38 |
| 52 Week Low | $10.87 | $6.00 |
| 52 Week High | $27.13 | $11.31 |
Technical Indicators
Market Signals| Indicator | IART | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.26 | 53.18 |
| Support Level | $10.91 | $6.71 |
| Resistance Level | $13.43 | $7.17 |
| Average True Range (ATR) | 0.61 | 0.25 |
| MACD | 0.25 | 0.02 |
| Stochastic Oscillator | 84.13 | 77.85 |
Price Performance
Historical ComparisonAbout IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.